Assembly Biosciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $32.3M | $31.1M | $58.5M | $22.5M | $24.0M | $23.4M | $38.3M | $28.5M |
| Accounts Receivable | $822.0K | $451.0K | $974.0K | $912.0K | — | — | $0 | $0 |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $328.0M | $232.6M | $254.5M | $236.8M | $77.5M | $95.5M | $115.5M | $98.2M |
| Property, Plant & Equipment | $315.0K | $214.0K | $221.0K | $229.0K | $219.0K | $251.0K | $284.0K | $316.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $330.8M | $235.5M | $257.6M | $240.0M | $80.8M | $99.0M | $119.2M | $100.3M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $1.1M | $1.2M | $1.7M | $743.0K | $875.0K | $585.0K | $1.3M |
| Total Current Liabilities | $23.4M | $35.0M | $48.8M | $53.4M | $47.3M | $46.6M | $47.8M | $41.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $25.2M | $36.9M | $50.8M | $57.3M | $62.7M | $71.9M | $85.8M | $74.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-845.0M | $-841.1M | $-832.0M | $-854.1M | $-844.9M | $-834.7M | $-825.9M | $-815.6M |
| Total Stockholders' Equity | $305.6M | $198.6M | $206.8M | $182.7M | $18.1M | $27.1M | $33.4M | $26.0M |